Entrepreneur Briefs

From Orphan To Startup After being bought and sold and then finally told that he just wasn’t wanted anymore, computer scientist David Jenkins is now calling the shots for his own computer hardware company, Visionary Systems Inc. of New Haven, Conn. It all began in 1986 when Jenkins was working on microchips for array processing boards as part of ITT’s Advanced Technology Center in Shelton, Conn. In December of that year, ITT sold Jenkins’ Cellular Array Processor project, alo

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

After being bought and sold and then finally told that he just wasn’t wanted anymore, computer scientist David Jenkins is now calling the shots for his own computer hardware company, Visionary Systems Inc. of New Haven, Conn. It all began in 1986 when Jenkins was working on microchips for array processing boards as part of ITT’s Advanced Technology Center in Shelton, Conn. In December of that year, ITT sold Jenkins’ Cellular Array Processor project, along with its 29 other Shelton-based research projects, to Alcatel N.y., a French telecommunications company. Less than a year later, however, Alcatel closed down all the projects, including Jenkins’ operation. That’s when Jenkins formed Visionary Systems, which develops array processing boards for PCs. The company’s first product now being tested is called the APx Accelerator, which he says will bring “high computing power at low-cost in a desktop machine.” Since the computer accelerator board can be ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies